These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 2345558
1. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A. Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558 [Abstract] [Full Text] [Related]
2. Antibodies to motor endplates demonstrated with the immunofluorescence technique. Sondag-Tschroots IR, Schulz-Raateland RC, van Walbeek HK, Feltkamp TE. Clin Exp Immunol; 1979 Aug; 37(2):323-7. PubMed ID: 387311 [Abstract] [Full Text] [Related]
5. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases. Vincent A, Cull-Candy SG, Newsom-Davis J, Trautmann A, Molenaar PC, Polak RL. Muscle Nerve; 1981 Aug; 4(4):306-18. PubMed ID: 7254233 [Abstract] [Full Text] [Related]
6. Passive transfer of seronegative myasthenia gravis to mice. Burges J, Vincent A, Molenaar PC, Newsom-Davis J, Peers C, Wray D. Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240 [Abstract] [Full Text] [Related]
7. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Uchitel O, Engel AG, Walls TJ, Nagel A, Atassi MZ, Bril V. Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384 [Abstract] [Full Text] [Related]
8. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction. Molenaar PC, Oen BS, Plomp JJ, Van Kempen GT, Jennekens FG, Hesselmans LF. Eur J Pharmacol; 1991 Apr 10; 196(1):93-101. PubMed ID: 1874282 [Abstract] [Full Text] [Related]
11. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia. Niks EH, Kuks JB, Wokke JH, Veldman H, Bakker E, Verschuuren JJ, Plomp JJ. Muscle Nerve; 2010 Aug 10; 42(2):283-8. PubMed ID: 20544919 [Abstract] [Full Text] [Related]
12. Experimental autoimmune myasthenia gravis: the rabbit as an animal model. Eldefrawi ME. Fed Proc; 1978 Dec 10; 37(14):2823-7. PubMed ID: 720635 [Abstract] [Full Text] [Related]
13. Neuromuscular defect after suppression of ion conductance. Takamori M, Ide Y, Kasai M. Neurology; 1979 Jun 10; 29(6):772-9. PubMed ID: 221854 [Abstract] [Full Text] [Related]
14. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)]. Hohlfeld R, Wekerle H. MMW Munch Med Wochenschr; 1981 Jul 31; 123(31):1207-11. PubMed ID: 6790965 [Abstract] [Full Text] [Related]
15. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Cole RN, Reddel SW, Gervásio OL, Phillips WD. Ann Neurol; 2008 Jun 31; 63(6):782-9. PubMed ID: 18384168 [Abstract] [Full Text] [Related]
16. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis. Mittag T, Massa T, Kornfeld P, Papatestas A, Bender A, Genkins G. Muscle Nerve; 1981 Jun 31; 4(1):16-25. PubMed ID: 6164920 [Abstract] [Full Text] [Related]
17. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect. Mossman S, Vincent A, Newsom-Davis J. J Neurol Sci; 1988 Mar 31; 84(1):15-28. PubMed ID: 2835437 [Abstract] [Full Text] [Related]
18. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria. Gomez CM, Richman DP. J Immunol; 1987 Jul 01; 139(1):73-6. PubMed ID: 3035025 [Abstract] [Full Text] [Related]